[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Davidson R., Gardner S., Jupp O., Bullough A., Butters S., Watts L., Donell S., Traka M., Saha S., Mithen R., et al
Nat Commun 15:4548 Wharton S, Calanna S, Davies M et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between Gastrointestinal adverse events and weight loss
GLP-1 receptors are found throughout the body, including in the pancreas, gastrointestinal tract, and certain brain regions involved in appetite regulation and glucose homeostasis
These can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reflux, and reduced appetite